TIMP-2 promotes activation of progelatinase a by membrane-type 1 matrix metalloproteinase immobilized on agarose beads

被引:247
作者
Kinoshita, T
Sato, H
Akiko
Okada
Ohuchi, E
Imai, K
Okada, Y
Seiki, M
机构
[1] Univ Tokyo, Inst Med Sci, Dept Canc Cell Res, Minato Ku, Tokyo 108, Japan
[2] Kanazawa Univ, Canc Res Inst, Dept Mol Virol & Oncol, Kanazawa, Ishikawa 920, Japan
[3] Kanazawa Univ, Canc Res Inst, Dept Mol Pathol & Immunol, Kanazawa, Ishikawa 920, Japan
[4] Fuji Chem Ind Ltd, Dept Biopharmaceut, Toyama 933, Japan
[5] Keio Univ, Sch Med, Dept Pathol, Shinnjyuku Ku, Tokyo 160, Japan
关键词
D O I
10.1074/jbc.273.26.16098
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Membrane-type 1 matrix metalloproteinase (MT1-MMP)/MMP-14 is the activator of progelatinase A (proGelA)/proMMP-2 on the cell surface. However, it was a paradox that a tissue inhibitor of metalloproteinase-2 (TIMP-2), which is an inhibitor of MT1-MMP, is required for proGelA activation by the cells expressing MT1-MMP. In this study, a truncated MT1-MMP having a FLAG-tag sequence at the C terminus (MT1-F) was immobilized onto agarose beads (MT1-F/B) and used to analyze the role of TIMP-2, The proteolytic activity of MT1-F/B against a synthetic peptide substrate was inhibited by TIMP-2 in a dose-dependent manner. In contrast, TIMP-2 promoted the processing of proGelA by MT1-F/B at low concentrations and inhibited it at higher concentrations. TIMP-2 promoted the binding of proGelA to the MT1-F on the beads by forming a trimolecular complex, which was followed by processing of proGelA. A stimulatory effect of TIMP-2 was observed under conditions in which unoccupied MT1-F was still available. Thus, the ternary complex is thought to act as a means to concentrate the substrate to the bead surface and to present it to the neighboring free MT1-F.
引用
收藏
页码:16098 / 16103
页数:6
相关论文
共 44 条
[1]   Proteinases and extracellular matrix remodeling [J].
Alexander, C. M. ;
Werb, Z. .
CURRENT OPINION IN CELL BIOLOGY, 1989, 1 (05) :974-982
[2]   Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes [J].
Atkinson, SJ ;
Crabbe, T ;
Cowell, S ;
Ward, RV ;
Butler, MJ ;
Sato, H ;
Seiki, M ;
Reynolds, JJ ;
Murphy, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (51) :30479-30485
[3]  
AZZAM HS, 1992, CANCER RES, V52, P4540
[4]   Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 [J].
Brooks, PC ;
Stromblad, S ;
Sanders, LC ;
vonSchalscha, TL ;
Aimes, RT ;
StetlerStevenson, WG ;
Quigley, JP ;
Cheresh, DA .
CELL, 1996, 85 (05) :683-693
[5]  
BROWN PD, 1990, CANCER RES, V50, P6184
[6]   CHARACTERIZATION OF THE FUNCTIONAL DOMAIN OF TISSUE INHIBITOR OF METALLOPROTEINASES-2 (TIMP-2) [J].
DECLERCK, YA ;
YEAN, TD ;
LEE, Y ;
TOMICH, JM ;
LANGLEY, KE .
BIOCHEMICAL JOURNAL, 1993, 289 :65-69
[7]  
EMONARD HP, 1992, CANCER RES, V52, P5845
[8]  
FRIDMAN R, 1992, J BIOL CHEM, V267, P15398
[9]   Carbohydrate-mediated regulation of matrix metalloproteinase-2 activation in normal human fibroblasts and fibrosarcoma cells [J].
Gervasi, DC ;
Raz, A ;
Dehem, M ;
Yang, MZ ;
Kurkinen, M ;
Fridman, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 228 (02) :530-538
[10]  
Gilles C, 1996, INT J CANCER, V65, P209